We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

PBD Biotech

PBD Biotech is developing phage-based diagnostics for mycobacteria to achieve the goals of the World Health Oraganization's "End TB Strategy".

Latest Content

3D computer-generated image of Mycobacterium tuberculosis bacteria.

Product News

Actiphage Enters New Clinical Trial Aimed at Early Tuberculosis Diagnosis

A new clinical trial of a ground-breaking phage-based molecular diagnostic, has been agreed. The trial is aimed at evaluating the performance of the phage assay as a first-line blood-based diagnostic for active pulmonary Tuberculosis.

Industry Insight

Exploiting Bacteriophage as a Diagnostic Tool

Technology Networks spoke to Dr. Tomas Richardson from PBD Biotech, to hear more about how bacteriophage can be used to diagnose tuberculosis in both humans and cattle.

Never miss a story

with the Breaking Science News daily newsletter